Littérature

Recommandations des sociétés nationales et des sociétés d’experts

• SwissNoso http://www.chuv.ch/swiss-noso/f114a2.htm
• Dutch Guideline for Preventing Nosocomial Transmission of Highly Resistant Microorganisms (HRMO) http://www.springerlink.com/content/b841575n57056h4w/
• Preventing Transmission of Infectious Agents in Healthcare Settings. www.hicpac.org
• Witte, Bundesgesundheitsblatt 2003; 46:881
• Canada: www.gov.mb.ca/health/publichealth/cdc/fs/esbl.pdf
• Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance:
• Guidelines for the Prevention of Antimicrobial Resistance in Hospitals: http://www.journals.uchicago.edu/CID/journal/issues/v25n3/se39_584/se39_584.web.pdf
• Preventing Transmission of Multidrug-Resistant Bacteria in Health Care Settings: A Tale of Two Guidelines:2006 http://www.journals.uchicago.edu/CID/journal/issues/v42n6/38184/38184.html
• WHO 2001, www.who.int/emc/amrpdfs/Infection_control_programmes_to_contain_antimicrobial_re.pdf
• Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques http://www.sante.gouv.fr/htm/pointsur/nosoco/bacteries/maitbact.html

Epidémiologie

• Wiener, JAMA 1999;281:517
• Bradford, P. Clin Microbiol Rev 2001;14:933-51.
• Dancer, J Antimicrob Chemother 2001;48:463;
• Arpin, Antimicrob Agents Chemother 2003;47:3506
• Paterson, Clin Infect Dis 2004;38:34
• Rodriguez-Bano, J Clin Microbiol 2004;42:1089
• Woodford N.J Antimicrob Chemother. 2007. 59:102-105.

ESBL et environnement

• Eisen, J Clin Microbiol 1995;33:713
• Hobson, J Hosp Infect 1996;33:249
• Branger, J Hosp Infect 1997;36:23
• Gaillot, J Clin Microbiol 1998;36:1357
• Szabó, J Clin Microbiol 1999;37:4167
• Rogues, J Hosp Infect 2000;45:76
• Cotton, J Hosp Infect 2000;44:13
• Gupta, Infect Control Hosp Epidemiol 2004;25:210

ESBL et personnel de soins

• Hobson, J Hosp Infect 1996;33:249; French, J Clin Microbiol 1996;34:358
• Mhand, J Clin Microbiol 1999;37:3769;
• Hammami, Eur J Clin Microbiol Infect Dis 1991;10:641
• ESBL et colonisation digestive
• Peña, Antimicrob Agents Chemother 1998;42:53;
• Lucet, Clin Infect Dis 1999;29:1411

ESBL et Mécanismes de résistance

• Rahal, JAMA 1998;280:1233;
• Patterson, Infect Control Hosp Epidemiol 2000;21:455
• Patterson, Chest 2001;119:426

ESBL et établissements longs séjours

• Bird, J Hosp Infect 1998;40:243
• Wiener, JAMA 1999;281:517
• Nicolle, Infect Control Hosp Epidemiol 2000;21:537
• McNulty, J Hosp Infect 2003;55:119
• Mody, Infect Control Hosp Epidemiol 2001;22:193;

ESBL et décolonisation

• Brun-Buisson, Ann Intern Med 1989;110:873
• De Champs, Intensive Care Med 1993;19:191;
• Taylor, J Hosp Infect 1991;17:271;
• Decré, Clin Infect Dis 1998;27:834.
• Paterson, Clin Infect Dis 2000;30:473
• Paterson, Clin Infect Dis 2001;33:126
• Ungheri, J Chemother 2002;14:237.
• Schito, Int J Antimicrob Agents 2003;22:79
• Alhambra, J Antimicrob Chemother 2004;53:1090;

Dernière modification le 02.04.2007